← Back to news
Clinical trialCLINICALTRIALSThursday, March 26, 2026 · March 26, 2026

Trial Now Recruiting: Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network (NCT02450851)

WHY IT MATTERS

If you or a family member has spent years seeking a diagnosis without answers, this large national study offers free genetic evaluation and expert medical review specifically designed to identify undiagnosed rare diseases.

Researchers are looking for 20,000 people with rare diseases that doctors haven't been able to diagnose yet. Many patients spend years going to different doctors and getting repeated tests without finding answers. This study, run by the National Human Genome Research Institute, aims to help solve medical mysteries by using genetic testing and careful evaluation to figure out what's causing people's symptoms.

NCT ID: NCT02450851 Status: RECRUITING Conditions: Genetic Disease Enrollment: 20000 Sponsor: National Human Genome Research Institute (NHGRI) Summary: Without an explanation for severe and sometimes life-threatening symptoms, patients and their families are left in a state of unknown. Many individuals find themselves being passed from physician to physician, undergoing countless and often repetitive tests in the hopes of finding answers and insight about what the future may hold. This long and arduous journey to find a diagnosis does not end for many patients- the Office of Rare Diseases Research (ORDR) notes that 6% of individuals seeking the

YOU CAN ACT ON THIS

Visit clinicaltrials.gov and search NCT02450851 to see if you qualify and how to contact the nearest Undiagnosed Diseases Network site to apply.

Find clinical trials →Learn more ↗
undiagnosed diseasesgenetic testingclinical trial recruitingrare disease diagnosisudnnetwork

Related news

Researchpubmed · April 1, 2026
Advancing Neuropediatric Rare Disease Diagnosis Through Clinical Genome Sequencing.
Researchers in Italy tested a new way to diagnose rare genetic diseases in children using whole genome sequencing—a test